EP4323333A1 - A process for preparation of substituted enamine compounds - Google Patents

A process for preparation of substituted enamine compounds

Info

Publication number
EP4323333A1
EP4323333A1 EP22720626.5A EP22720626A EP4323333A1 EP 4323333 A1 EP4323333 A1 EP 4323333A1 EP 22720626 A EP22720626 A EP 22720626A EP 4323333 A1 EP4323333 A1 EP 4323333A1
Authority
EP
European Patent Office
Prior art keywords
compound
formula
methyl
ethyl
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22720626.5A
Other languages
German (de)
French (fr)
Inventor
Werner Bonrath
Le DAI
Xixiang DAI
Qi Gu
Qiangqiang LIU
Maurus Marty
Marc-André Mueller
Kun Peng
Liuhai WU
Zili Zhang
Florian ZIEGLER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of EP4323333A1 publication Critical patent/EP4323333A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/30—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same unsaturated acyclic carbon skeleton

Definitions

  • the present invention is related to a new process for producing substituted enamine compounds.
  • Oxazole compounds represent a vast class of heterocyclic aromatic organic compounds. Oxazole compounds have become increasingly important because of biological activities and their use as intermediates for the preparation of new biological materials.
  • the wide range of biological activities of oxazole compounds includes anti-inflammatory, analgesic, antibacterial, antifungal, hypoglycemic, antiproliferative, anti-tuberculosis, muscle relaxant and HIV inhibitor activity.
  • oxazole derivatives are important intermediates for preparation of biological compounds such as vitamin B 6 .
  • oxazole compounds Various processes for the preparation of oxazole compounds have been developed.
  • One preferred process in industry is from alanine and oxalic acid in ethanol carried out by azeotropic distillation with benzene.
  • the ring closure reaction to obtain 5-ethoxy-4-methyloxazole can also be carried out using phosgene or triphosgene, which is toxic and not environment friendly (see CN 104725262 B, CN 102898321 A and CN 105985297 A)
  • the present invention provides a substituted enamine compound of formula (I), which can be converted to an oxazole compound, wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
  • the present invention also provides a process for producing the compound of formula (I) and a process for producing oxazole compounds from the compound of formula (I).
  • the term "lower alkyl” as used refers to Ci-Cio alkyl, i.e., branched or unbranched, cyclic or non-cyclic, saturated hydrocarbon comprising 1-10 carbon atoms.
  • the "lower alkyl” is Ci-C 6 alkyl, including but not limited to methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, tert- butyl, cyclobutyl, pentyl, iso-pentyl, tert-pentyl, cyclopentyl, hexyl, isohexyl, tert-hexyl, cyclohexyl, octyl, isooctyl, tert-octyl, cyclooctyl, nonyl, isononyl, tert-nonyl, cyclon
  • aryl refers to aromatic hydrocarbon such as phenyl, benzyl, xylyl and naphthalenyl.
  • lower alkoxyl refers to the structure represented by (lower alkyl)-0-, wherein the lower alkyl is defined as above.
  • halo or halogen refers to a group of elements including fluorine (F), chlorine (Cl), bromine (Br) and iodine (I), preferably refers to Cl or Br.
  • substitutedine or substituted refers to lower alkyl, lower alkoxyl, hydroxyl, halo, -NH 2 , -N0 2 , cyano or isocyano.
  • a compound represented by a formula or a name also cover stereoisomers thereof, including diastereomers and enantiomers, such as cis/trans-isomers or E/Z-isomers.
  • the present invention provides a process for producing a compound of formula (I), comprising reacting a compound of formula (II) with a compound of formula (III) to produce the compound of formula (I), wherein
  • R is H, lower alkyl or aryl, optionally substituted by one or more substituents
  • R' is H; and any two of Ri, R 2 and R 3 , together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, lower alkyl, lower alkoxyl, aryl, or NR 4 R 4 ' (wherein R and R ' are dependently H or lower alkyl), optionally substituted by one or more substituents; or R', Ri, R 2 and R 3 , together with the carbon they connect, form carbon monoxide (Co0).
  • R is H or Ci-C 6 alkyl, optionally substituted by one or more substituents. More preferably, R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents. The most preferably, R is H or methyl.
  • the rest one is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents.
  • R is H, methyl, ethyl or phenyl; and any two of Ri, R 2 and R 3 , together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, or NR R ' (wherein R and R ' are dependently H, methyl or ethyl).
  • R is H, methyl, ethyl or phenyl
  • the compound of formula (III) is carbon monoxide.
  • R is H or methyl; and any two of Ri, R 2 and R 3 , together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, -NH 2 or -NHCH 3 .
  • the compound of formula (I) and (II) may be in a form of any salt of formula (G) and (IG) respectively: wherein R is defined as above, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), potassium (K), and cesium (Cs)), or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), and barium (Ba)), or Iron (ll/lll); or ammonium (NH ) or substituted ammonium.
  • X and Y are dependently Na or K.
  • the compound of formula (III) may be added in an amount of from 0.01 mols to 20 moles, preferably from 0.05 moles to 15 moles, more preferably from 0.1 mole to 10 moles such as 0.2, 0.5, 0.8, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0 and 10 moles, per 1 mole of the compound of formula (II).
  • the process of the present invention may be carried out in the presence of a solvent.
  • the solvent may be an inorganic solvent such as liquid ammonia, or an organic solvent including but not limited to alkane such as pentane, hexane, heptane, cyclopentane and cyclohexane, aromatic hydrocarbon such as benzene and toluene, ester such as methyl formate and ethyl formate, alcohol such as ethanol, ether such as methyl tert-butyl ether (TBME) and cyclopentyl methyl ether, tertiary amine such as N,N-diethylaniline, triethylamine and tributylamine, amide such as dimethylformamide (DMF), diethylformamide (DEF) and dibutylformamide (DBF), acetonitrile, tetrahydrofuran (THF), 2-methyltetrahydrofuran (MeTHF), or
  • the solvent is liquid ammonia, toluene, THF, heptane, acetonitrile, methyl formate, N,N- diethylaniline, triethylamine, TBME, cyclopentyl methyl ether, toluene, ethanol, or mixture thereof.
  • the solvent is liquid ammonia, toluene, heptane, acetonitrile, methyl formate, TBME, or mixture thereof.
  • the compound of formula (III) is methyl formate
  • the solvent is selected from the group consisting of liquid ammonia, heptane, acetonitrile, methyl formate, N,N-diethylaniline, triethylamine, TBME, cyclopentyl methyl ether and toluene, and mixture thereof.
  • the compound of formula (III) is ethyl formate
  • the solvent is selected from the group consisting of liquid ammonia, toluene, THF and heptane, and mixture thereof.
  • the solvent may be added in an amount of from 0.05 mL to 10 mL, preferably from 0.1 mL to 9 mL, more preferably from 0.15 mL to 5 mL such as 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 2, 3, 4 and 5 mL, per 1 mmol of the compound of formula (II).
  • the reaction of the present invention may be carried out at the temperature from -50°C to 110°C, preferably from -40°C to 100°C, more preferably from -10°C to 50°C such as -10, -5, 0, 10, 15, 20, 25, 30, 35, 40, 45 and 50°C, under a pressure at 1-20 bar, preferably 2-15 bar, more preferably 3-10 bar such as 3, 4, 5, 6, 7, 8, 9 and 10 bar.
  • the obtained compound of formula (la) may be used to the next step b) directly or purified by known process such as crystallization and/or filtration.
  • the compound of formula (II) may be prepared by any process known in the art in-situ or ex-situ, for example, by treating the compound of formula (I la) with a strong base such as sodium methoxide, sodium ethoxide, sodium hydride (NaH) and sodium amide.
  • a strong base such as sodium methoxide, sodium ethoxide, sodium hydride (NaH) and sodium amide.
  • the compound of formula (II) maybe produced from nitriles such as acetonitrile as disclosed in US 5187297 A.
  • R is defined as above.
  • the compound of formula (I) according to the present invention can be used for producing oxazole compounds.
  • the whole process for producing oxazole compounds avoid toxic and unsafe reagents while providing high yield and high selectivity.
  • the present invention provides a process for producing an oxazole compound comprising the step of producing the compound of formula (I) as defined above.
  • the process of the present invention avoids toxic phosphate reagents and saves steps compared to the processes known in the art and thus provides a new process.
  • the present invention will be further illustrated by the following examples.
  • a dried four necked round bottom flask was charged with liquid ammonia (15 mL, 0.615 mol, 11 eq). After the flask was flushed with argon, sodium (1.5 g, 65 mmol, 1.1 eq) was added and stirred for 30 mins at - 40°C to -50°C. At the same temperature compound 1 (4.85 g, 59 mmol, 1 eq) in THF (20 mL) was added dropwise in 15 mins. Then the reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a white suspension of the compound 2.
  • This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2 (19.40 g, 67.1wt% purity, 97% yield).
  • a dried autoclave was charged at -40°C to -50°C with liquid ammonia (887 mL, 36 mol, 46 eq) and iron nitrate nonahydrate (210 mg, 0.97 mmol, 0.001 eq). Then sodium (18.0 g, 783 mmol, 1.0 eq) was added, and the reaction mixture stirred for 30 min at -40°C to -50°C until complete cessation of hydrogen evolution. The reaction mixture was heated to 20°C over a period of 45 min, whereas a pressure of 8 bar formed. At the same temperature anhydrous acetonitrile (64.2 g, 1,564 mmol, 2.0 eq) was pumped over a period of 15 min, and the reaction mixture was stirred for 150 min.
  • Example 9 The filter cake obtained according to the same procedures of Example 9 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (100 mL) was added and acetic acid (7.75 g, 129 mmol, 1.0 eq) was added dropwise in 5 mins. The reaction mixture was stirred for 30 mins at room temperature and then filtered over a paper filter (7 cm diameter). The filtrate was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (13.22 g, 98.8wt% purity,

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a substituted enamine compound of formula (I), and a process for producing oxazole compounds from the compound of formula (I). According to the processes of the present invention, it can produce substituted enamine compounds with high yield and selectivity while avoiding toxic or unsafe reagents for producing oxazole compounds.wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.

Description

A process for preparation of substituted enamine compounds
Technical Field
The present invention is related to a new process for producing substituted enamine compounds.
Background of the Invention
Oxazole compounds represent a vast class of heterocyclic aromatic organic compounds. Oxazole compounds have become increasingly important because of biological activities and their use as intermediates for the preparation of new biological materials. The wide range of biological activities of oxazole compounds includes anti-inflammatory, analgesic, antibacterial, antifungal, hypoglycemic, antiproliferative, anti-tuberculosis, muscle relaxant and HIV inhibitor activity. In addition, oxazole derivatives are important intermediates for preparation of biological compounds such as vitamin B6.
Various processes for the preparation of oxazole compounds have been developed. One preferred process in industry is from alanine and oxalic acid in ethanol carried out by azeotropic distillation with benzene. Following this concept, the ring closure reaction to obtain 5-ethoxy-4-methyloxazole can also be carried out using phosgene or triphosgene, which is toxic and not environment friendly (see CN 104725262 B, CN 102898321 A and CN 105985297 A)
In recent years, one attractive process is direct cyclodehydration of acyloxy enamines because acyloxy enamines have been introduced early N-atom and installed the carboxylic acids. It was reported that acyloxy enamines can be synthesized by intermolecular oxidative coupling of an enamine compound with carboxylic acid by using iodosobenzene as the oxidant. However, the oxidant iodosobenzene is highly flammable and has explosion risk. In addition, iodosobenzene is not soluble in solvents and thus results in unstable yields of the process (see Xin Liu et al., Org. Lett., Vol. 14, No. 21, 2012).
Therefore, there is still demand of a new process for the preparation of substituted enamines, which can be converted to oxazole compounds, in industry.
Summary of the Invention The present invention provides a substituted enamine compound of formula (I), which can be converted to an oxazole compound, wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
The present invention also provides a process for producing the compound of formula (I) and a process for producing oxazole compounds from the compound of formula (I).
According to the processes of the present invention, it can produce substituted enamine compounds with high yield and selectivity, while avoiding toxic or unsafe reagents for producing oxazole compounds.
Detailed Description of the Invention
In the present invention, the term "lower alkyl" as used refers to Ci-Cio alkyl, i.e., branched or unbranched, cyclic or non-cyclic, saturated hydrocarbon comprising 1-10 carbon atoms. Preferably, the "lower alkyl" is Ci-C6 alkyl, including but not limited to methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, tert- butyl, cyclobutyl, pentyl, iso-pentyl, tert-pentyl, cyclopentyl, hexyl, isohexyl, tert-hexyl, cyclohexyl, octyl, isooctyl, tert-octyl, cyclooctyl, nonyl, isononyl, tert-nonyl, cyclononyl, decyl, isodecyl, tert-decyl, cyclodecyl. More preferably, the "lower alkyl" is methyl or ethyl.
In the present invention, the term "aryl" as used refers to aromatic hydrocarbon such as phenyl, benzyl, xylyl and naphthalenyl.
In the present invention, the term "lower alkoxyl" as used refers to the structure represented by (lower alkyl)-0-, wherein the lower alkyl is defined as above.
In the present invention, the term "halo" or "halogen" as used refers to a group of elements including fluorine (F), chlorine (Cl), bromine (Br) and iodine (I), preferably refers to Cl or Br. In the present invention, the term "substituents" or "substituent" as used refers to lower alkyl, lower alkoxyl, hydroxyl, halo, -NH2, -N02, cyano or isocyano.
In the present invention, a compound represented by a formula or a name also cover stereoisomers thereof, including diastereomers and enantiomers, such as cis/trans-isomers or E/Z-isomers.
In the first aspect of the present invention, it provides a process for producing a compound of formula (I), comprising reacting a compound of formula (II) with a compound of formula (III) to produce the compound of formula (I), wherein
R is H, lower alkyl or aryl, optionally substituted by one or more substituents; and
R' is H; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, lower alkyl, lower alkoxyl, aryl, or NR4R4' (wherein R and R ' are dependently H or lower alkyl), optionally substituted by one or more substituents; or R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (Cº0).
Preferably, R is H or Ci-C6 alkyl, optionally substituted by one or more substituents. More preferably, R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents. The most preferably, R is H or methyl.
Preferably, any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, Ci-C6 lower alkyl, Ci-C6 lower alkoxyl, aryl, or NR4R4' (wherein R and R ' are dependently H or Ci-C6 lower alkyl), optionally substituted by one or more substituents. More preferably, the rest one is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents. The most preferably, the rest one is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl), optionally substituted by one or more substituents. More preferably, R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (C=0).
In one embodiment,
R is H, methyl, ethyl or phenyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, or NR R ' (wherein R and R ' are dependently H, methyl or ethyl).
In another embodiment,
R is H, methyl, ethyl or phenyl; and
The compound of formula (III) is carbon monoxide.
In one preferable embodiment,
R is H or methyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, -NH2 or -NHCH3.
In the present invention, the compound of formula (I) and (II) may be in a form of any salt of formula (G) and (IG) respectively: wherein R is defined as above, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), potassium (K), and cesium (Cs)), or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), and barium (Ba)), or Iron (ll/lll); or ammonium (NH ) or substituted ammonium. Preferably, X and Y are dependently Na or K.
In the process of the present invention, the compound of formula (III) may be added in an amount of from 0.01 mols to 20 moles, preferably from 0.05 moles to 15 moles, more preferably from 0.1 mole to 10 moles such as 0.2, 0.5, 0.8, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0 and 10 moles, per 1 mole of the compound of formula (II).
The process of the present invention may be carried out in the presence of a solvent. The solvent may be an inorganic solvent such as liquid ammonia, or an organic solvent including but not limited to alkane such as pentane, hexane, heptane, cyclopentane and cyclohexane, aromatic hydrocarbon such as benzene and toluene, ester such as methyl formate and ethyl formate, alcohol such as ethanol, ether such as methyl tert-butyl ether (TBME) and cyclopentyl methyl ether, tertiary amine such as N,N-diethylaniline, triethylamine and tributylamine, amide such as dimethylformamide (DMF), diethylformamide (DEF) and dibutylformamide (DBF), acetonitrile, tetrahydrofuran (THF), 2-methyltetrahydrofuran (MeTHF), or mixture thereof.
More preferably, the solvent is liquid ammonia, toluene, THF, heptane, acetonitrile, methyl formate, N,N- diethylaniline, triethylamine, TBME, cyclopentyl methyl ether, toluene, ethanol, or mixture thereof. The most preferably, the solvent is liquid ammonia, toluene, heptane, acetonitrile, methyl formate, TBME, or mixture thereof.
In one embodiment, the compound of formula (III) is methyl formate, and the solvent is selected from the group consisting of liquid ammonia, heptane, acetonitrile, methyl formate, N,N-diethylaniline, triethylamine, TBME, cyclopentyl methyl ether and toluene, and mixture thereof.
In another embodiment, the compound of formula (III) is ethyl formate, and the solvent is selected from the group consisting of liquid ammonia, toluene, THF and heptane, and mixture thereof.
In the process of the present invention, the solvent may be added in an amount of from 0.05 mL to 10 mL, preferably from 0.1 mL to 9 mL, more preferably from 0.15 mL to 5 mL such as 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 2, 3, 4 and 5 mL, per 1 mmol of the compound of formula (II).
The reaction of the present invention may be carried out at the temperature from -50°C to 110°C, preferably from -40°C to 100°C, more preferably from -10°C to 50°C such as -10, -5, 0, 10, 15, 20, 25, 30, 35, 40, 45 and 50°C, under a pressure at 1-20 bar, preferably 2-15 bar, more preferably 3-10 bar such as 3, 4, 5, 6, 7, 8, 9 and 10 bar. After the reaction finishes, the obtained compound of formula (la) may be used to the next step b) directly or purified by known process such as crystallization and/or filtration.
The compound of formula (II) may be prepared by any process known in the art in-situ or ex-situ, for example, by treating the compound of formula (I la) with a strong base such as sodium methoxide, sodium ethoxide, sodium hydride (NaH) and sodium amide.
Wherein Ri is as defined above.
Alternatively, the compound of formula (II) maybe produced from nitriles such as acetonitrile as disclosed in US 5187297 A.
The inventor of the present invention surprisingly discovered that the compound of formula (I) according to the present invention is new. Accordingly, in the second aspect of the present invention, it provides a compound of formula (I),
Wherein R is defined as above.
As described above, the compound of formula (I) according to the present invention can be used for producing oxazole compounds. As a result, the whole process for producing oxazole compounds avoid toxic and unsafe reagents while providing high yield and high selectivity.
In the third aspect of the present invention, it provides a process for producing an oxazole compound comprising the step of producing the compound of formula (I) as defined above. The process of the present invention avoids toxic phosphate reagents and saves steps compared to the processes known in the art and thus provides a new process. The present invention will be further illustrated by the following examples.
Examples
Example 1
1 2
A dried four necked round bottom flask was charged with liquid ammonia (15 mL, 0.615 mol, 11 eq). After the flask was flushed with argon, sodium (1.5 g, 65 mmol, 1.1 eq) was added and stirred for 30 mins at - 40°C to -50°C. At the same temperature compound 1 (4.85 g, 59 mmol, 1 eq) in THF (20 mL) was added dropwise in 15 mins. Then the reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a white suspension of the compound 2.
1H NMR of f/Z-isomers of compound 2 (400 MHz, DMSO) d (ppm): 1.74 (3H) (46.7%), 1.53 (3H) (53.3%).
Example 2
2
A dried four necked round bottom flask was charged with liquid ammonia (50 mL, 2.05 mol, 16 eq). After the flask was flushed with argon, iron nitrate nonahydrate (35 mg, 0.087 mmol, 0.00067 eq) was added. Then sodium (2.96 g, 129 mmol, 1.0 eq) was added and stirred for 30 mins at -40°C to -50°C. At the same temperature anhydrous acetonitrile (11.65 g, 283 mmol, 2.2 eq) was added dropwise in 15 mins and anhydrous toluene (40 mL) was added immediately. The reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a grey suspension.
This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2 (19.40 g, 67.1wt% purity, 97% yield).
Example 3
2
A dried four necked round bottom flask was charged with liquid ammonia (50 mL, 2.05 mol, 18.4 eq). After the flask was flushed with argon, iron nitrate nonahydrate (32 mg, 0.078 mmol, 0.0007 eq) was added. Then, potassium (4.36 g, 112 mmol, 1.0 eq) was added at -50°C and stirred for 30 mins at -40°C to -50°C. At the same temperature anhydrous acetonitrile (10.07 g, 245 mmol, 2.2 eq) was added dropwise in 15 mins and anhydrous acetonitrile (35 mL) was added immediately. The reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a grey suspension.
This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2 (12.56 g, 93% yield).
Example 4
A dried four necked round bottom flask was charged with liquid ammonia (50 mL, 2.05 mol, 16 eq) and anhydrous heptane (5 mL, 34.1 mmol, 0.26 eq). After the flask was flushed with argon, iron nitrate nonahydrate (35 mg, 0.087 mmol, 0.00067 eq) was added. Then sodium (2.96 g, 129 mmol, 1.0 eq) was added and stirred for 30 mins at -40°C to -50°C. At the same temperature anhydrous acetonitrile (11.65 g, 283 mmol, 2.2 eq) was added dropwise in 15 mins and anhydrous heptane (35 mL) was added immediately. The reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a grey suspension.
Heptane (30 mL) was added to the grey suspension, and then ethyl formate (11.69 g, 154.8 mmol, 1.2 eq) dissolved in anhydrous heptane (20 mL) was added dropwise to the grey suspension during 20 mins. The reaction mixture was stirred for 2 hours to obtain a grey and thick suspension. N-butyl acetate (100 mL) was added and the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (19.30 g, 83 w/w% purity, 93% yield). JH NMR of E -isomer of compound 3 (400 MHz, DMSO) d (ppm): 8.81 (1H), 3.73 (1H), 1.82 (1H). NMR of Z-isomer of compound 3 (400 MHz, DMSO) d (ppm): 8.58 (1H), 4.21 (1H), 1.93 (3H).
Example 5
2 3
A dried autoclave was charged at -40°C to -50°C with liquid ammonia (887 mL, 36 mol, 46 eq) and iron nitrate nonahydrate (210 mg, 0.97 mmol, 0.001 eq). Then sodium (18.0 g, 783 mmol, 1.0 eq) was added, and the reaction mixture stirred for 30 min at -40°C to -50°C until complete cessation of hydrogen evolution. The reaction mixture was heated to 20°C over a period of 45 min, whereas a pressure of 8 bar formed. At the same temperature anhydrous acetonitrile (64.2 g, 1,564 mmol, 2.0 eq) was pumped over a period of 15 min, and the reaction mixture was stirred for 150 min. Ethyl formate (71.7 g, 949 mmol, 1.2 eq) was pumped over a period of 60 min and the reaction mixture was stirred for 8 h. All volatiles were evaporated to obtain compound 3 (76.8 g, 582 mmol, 74% yield).
Example 6
Ethyl formate (2.14 g, 29 mmol, 1.2 eq) was added dropwise to compound 2 (2.50 g, 24 mmol, 1.0 eq) obtained according to the same procedures of Example 2 in 20 min. The reaction mixture was stirred for 1.5 hours to obtain a grey slurry. TBME (30 mL) was added. Then, the mixture was filtrated over a paper filter to obtain a filter cake containing compound 3 (2.60 g, 82% yield).
Example 7
Ethyl formate (2.14 g, 29 mmol, 1.2 eq) was added dropwise to the grey suspension obtained according to the same procedures of Example 2 (2.50 g, 24 mmol, 1.0 eq) in 20 min. The reaction mixture was stirred for 1.5 hours to obtain a grey and thick suspension. TBME (30 mL) was added. Then, the mixture was filtrated over a paper filter (4.5 cm diameter) to obtain a filter cake containing compound 3 (2.65 g, 83% yield).
Example 8
2
3
Ethyl formate (10.49 g, 142 mmol, 1.1 eq) dissolved in acetonitrile (20 mL) was added dropwise to the grey suspension obtained according to the same procedures of Example 2 (13.43 g, 129 mmol, 1.0 eq) in 30 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.84 g, 93% yield).
Example 9
Ethyl formate (10.71 g, 142 mmol, 1.1 eq) dissolved in anhydrous toluene (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 in 20 mins. The reaction mixture was stirred overnight to obtain a grey and thick suspension. TBME (100 mL) was added and the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (49.68 g, 31.6wt% purity, 92% yield).
Example 10
Ethyl formate (4.82 g, 65 mmol, 0.5 eq) dissolved in THF (10 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 except that toluene was replaced with THF in 20 mins. The reaction mixture was stirred overnight to obtain a grey and thick suspension. TBME (100 mL) was added and the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (7.40 g, 82% yield).
Example 11
2 3
Methyl formate (9.28 g, 155 mmol, 1.2 eq) dissolved in heptane (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 except that toluene was replaced with heptane in 30 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.46 g, 91% yield).
Example 12
2
3 Methyl formate (8.51 g, 142 mmol, 1.1 eq) dissolved in acetonitrile (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 except that toluene was replaced with acetonitrile in 15 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.98 g, 94% yield).
Example 13
2
3
Methyl formate (8.51 g, 142 mmol, 1.1 eq) dissolved in N,N-diethylaniline (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 except that toluene was replaced with N,N-diethylaniline in 20 min and stirred for 10 min. Afterwards, additional methyl formate (47.0 g, 183 mmol, 6.1 eq) was added. The reaction mixture was stirred over night to obtain a grey and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (11.44 g, 67.2% yield).
Example 14
2 3
Methyl formate (8.51 g, 142 mmol, 1.1 eq) dissolved in triethylamine (20 mL) was added dropwise to the grey suspension (13.43g, 129 mmol, 1.0 eq) obtained according to the same procedures as Example 2 except that toluene was replaced with triethylamine in 20 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (13.97 g, 82% yield).
Example 15
Methyl formate (9.28 g, 155 mmol, 1.2 eq) dissolved in TBME (20 mL) was added dropwise to the grey suspension (13.43g, 129 mmol, 1.0 eq) obtained according to the same procedures as Example 2 except that toluene was replaced with TBME (13.43g, 129 mmol, 1.0 eq) in 30 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.19 g,
89% yield).
Example 16
©
© Na cyclopentyl methyl ether
2 3
Methyl formate (9.28 g, 155 mmol, 1.2 eq) dissolved in cyclopentyl methyl ether (20 mL) was added dropwise to the grey suspension (13.43g, 129 mmol, 1.0 eq) obtained according to the same procedures as Example 2 except that toluene was replaced with cyclopentyl methyl ether in 30 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (13.47 g, 79% yield).
Example 17
Dimethyl formamide (6.95 g, 95 mmol, 3 eq) dissolved in toluene (5 mL) was added dropwise to the grey suspension obtained according to the same procedures of Example 2 (3.3g, 31.7 mmol, 1.0 eq) in 10 min. The reaction mixture was stirred for 3 days at 40°Cto obtain a white suspension. TBME (50 mL) was added. Then, the mixture was filtrated over a paper filter (4 cm diameter) to obtain a filter cake containing compound 3 (1.98 g, 47% yield).
Example 18
Carbon monoxide (50 bar overpressure) was added to ethanol (10 mL) and the filter cake obtained according to the same procedures of Example 2 (347 mg, 3.33 mmol, 1.0 eq). The reaction mixture was shaked over 19 h at 70°C to obtain a yellow suspension. TBME (20 mL) was added. Then, the mixture was filtrated over a paper filter (2 cm diameter) to obtain a filter cake containing compound 3 (248 mg, 56% yield).
Example 19
The filter cake obtained according to the same procedures of Example 9 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (100 mL) was added and acetic acid (7.75 g, 129 mmol, 1.0 eq) was added dropwise in 5 mins. The reaction mixture was stirred for 30 mins at room temperature and then filtered over a paper filter (7 cm diameter). The filtrate was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (13.22 g, 98.8wt% purity,
92% yield).
To a solution of the compound 4 (220 mg, 2.0 mmol) in dried 1,2-dichloroethane (20 mL) was added BF3-Et20 (4.0 mmol, 2.0 eq). The reaction mixture was heated to reflux, and then phenyliodine(lll) diacetate (838 mg, 2.6 mmol, 1.3 eq) was added in one portion rapidly. After stirring under refluxing condition for 0.5-3 hours, the reaction mixture was cooled down to room temperature, quenched with saturated aqueous NaHC03, and then extracted with dichloromethane. The combined organic layer was washed with brine, dried over anhydrous Na2S0 and concentrated by the rotary evaporator. The crude product was purified by flash column chromatography to give the compound 5 (140 mg, 65% yield).

Claims

Claims
1. A process for producing a compound of formula (I), comprising: reacting a compound of formula (II) with a compound of formula (III) to produce a compound of formula
(I), wherein
R is H, lower alkyl or aryl, optionally substituted by one or more substituents; and
R' is H; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, lower alkyl, lower alkoxyl, aryl, or NR R ' (wherein R and R ' are dependently H or lower alkyl), optionally substituted by one or more substituents; or R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (Cº0).
2. The process of claim 1, wherein R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents.
3. The process of claim 1, wherein any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents
4. The process of claim 1, wherein R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (Cº0).
5. The process of claim 1, wherein R is H, methyl, ethyl or phenyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl).
6. The process of claim 1, wherein R is H, methyl, ethyl or phenyl; and the compound of formula (III) is carbon monoxide.
7. The process of claim 1, wherein R is H or methyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, -NH2 or -NHCH3.
8. The process of claim 1, wherein the compound of formula (I) and (II) are in a form of any salt of formula (G) and (IG) respectively:
(I·) (II·) wherein R is defined as any one of claims 1-7, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), potassium (K), and cesium (Cs)), or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), and barium (Ba)), or Iron (ll/lll); or ammonium (NH ) or substituted ammonium.
9. The process of any one of claims 1-8, wherein the reaction is carried out in the presence of a solvent.
10. The process of claim 9, wherein The solvent is an inorganic solvent such as liquid ammonia, or an organic solvent including but not limited to C5-Ci2 alkane such as pentane, hexane, heptane, cyclopentane and cyclohexane, aromatic hydrocarbon such as benzene and toluene, ester such as methyl formate and ethyl formate, alcohol such as ethanol, ether such as methyl tert-butyl ether (TBME) and cyclopentyl methyl ether, tertiary amine such as N,N-diethylaniline, triethylamine and tributylamine, amide such as dimethylformamide (DMF), diethylformamide (DEF) and dibutylformamide (DBF), acetonitrile, tetrahydrofuran (THF), 2-methyltetrahydrofuran (MeTHF), or mixture thereof.
11. The process of claim 9, wherein the solvent is liquid ammonia, toluene, THF, heptane, acetonitrile, methyl formate, N,N-diethylaniline, triethylamine, TBME, cyclopentyl methyl ether, toluene, ethanol, or mixture thereof.
12. The process of any one of claims 1-8, wherein the reaction is carried out at the temperature from - 50°C to 110°C, preferably from -40°C to 100°C, more preferably from -10°C to 50°C such as -10, -5, 0, 10, 15, 20, 25, 30, 35, 40, 45 and 50°C, under a pressure at 1-20 bar, preferably 2-15 bar, more preferably 3- 10 bar such as 3, 4, 5, 6, 7, 8, 9 and 10 bar.
13. The process of any one of claims 1-8, wherein the compound of formula (II) is prepared from the compound of formula (lla) or nitriles such as acetonitrile:
H2N
R ,/CN
(lla)
Wherein Ri is defined as any one of claims 1-8.
14. A compound of formula (I),
Wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
15. A process for producing an oxazole compound comprising the step of producing the compound of formula (I) according to any one of claims 1-13.
EP22720626.5A 2021-04-15 2022-04-04 A process for preparation of substituted enamine compounds Pending EP4323333A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2021087509 2021-04-15
PCT/EP2022/058839 WO2022218734A1 (en) 2021-04-15 2022-04-04 A process for preparation of substituted enamine compounds

Publications (1)

Publication Number Publication Date
EP4323333A1 true EP4323333A1 (en) 2024-02-21

Family

ID=81579557

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22720626.5A Pending EP4323333A1 (en) 2021-04-15 2022-04-04 A process for preparation of substituted enamine compounds

Country Status (3)

Country Link
EP (1) EP4323333A1 (en)
CN (1) CN117136179A (en)
WO (1) WO2022218734A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187297A (en) * 1990-11-05 1993-02-16 Lonza Ltd. Process for the production of 3-aminocrotononitrile
CN102898321B (en) 2011-07-24 2015-10-28 上海海嘉诺医药发展股份有限公司 Method for preparing N-butoxyoxalyl alanine butyl ester
CN104725262B (en) 2013-12-23 2018-05-15 大丰海嘉诺药业有限公司 A kind of continuous method for preparing N- ethyoxyl oxalyl alanine ethyl esters
CN105985297B (en) 2015-01-30 2018-08-10 湖北得正医药科技有限公司 The synthesis technology of vitamin B6 intermediate 4- methyl -5- ethyoxyl -2- oxazole acetoacetic esters
CN107652241B (en) * 2017-09-27 2020-03-31 新乡拓新药业股份有限公司 Method for synthesizing cytosine
CN111848449A (en) * 2019-04-30 2020-10-30 帝斯曼知识产权资产管理有限公司 A new acyloxyenamine compound
EP4136066A1 (en) * 2020-04-17 2023-02-22 DSM IP Assets B.V. A process for preparation of substituted enamine compounds

Also Published As

Publication number Publication date
WO2022218734A1 (en) 2022-10-20
CN117136179A (en) 2023-11-28

Similar Documents

Publication Publication Date Title
JP2024023340A (en) Preparation method of glufosinate ammonium
US20040186296A1 (en) Process to produce derivatives from uk-2a derivatives
WO1995032952A1 (en) Process for the preparation of 3-aryluracils
KR20020033617A (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
WO2021209269A1 (en) A process for preparation of substituted enamine compounds
KR101728443B1 (en) Method for Producing Benzyl Ester 2-aminonicotinicotinate Derivative
KR100980379B1 (en) Method for preparing 5-hydroxy-3-oxoheptanoate derivative having optical activity
WO2022218734A1 (en) A process for preparation of substituted enamine compounds
AU777959B2 (en) Process for preparing quinolylacrylonitrile and intermediates therefor
US20080004465A1 (en) Process for the Preparation of 4,4-Difluoro-3-Oxobutanoic Acid Esters
EP0808826B1 (en) A method for preparing 3-amino substituted crotonates
EP4323332A1 (en) A process for preparation of substituted enamine compounds
JP4138067B2 (en) Method for producing methine derivative
JP4032861B2 (en) Process for producing β-oxonitrile derivative or alkali metal salt thereof
HU209916B (en) Process for preparation of 2-aryl-5-/trifluoro-methyl/-pyrrole derivatives having insecticidal, acaricidal, nematocidal activity
JP2009518380A (en) Preparation of 2-chloroethoxy-acetic acid-N, N-dimethylamide
JP4929717B2 (en) Process for producing N, N'-dialkoxy-N, N'-dialkyloxamide
CN111556861A (en) Preparation method of jasmonate compound
CN119462612A (en) New method for preparing diaminopyrimidine derivatives or acid addition salts thereof
JP4561635B2 (en) Process for producing 4-alkoxycarbonyltetrahydropyran or tetrahydropyranyl-4-carboxylic acid
JP5205971B2 (en) Method for producing tetrahydropyran compound
JP4030289B2 (en) Process for producing β-ketonitriles
JPWO2005058859A1 (en) Process for producing 3- (4-tetrahydropyranyl) -3-oxopropanoic acid alkyl compound and 4-acyltetrahydropyran
JP3855686B2 (en) 3,3-dialkoxy-2-hydroxyimino derivative and process for producing the same
WO2023187833A1 (en) A novel salt of bempedoic acid

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20231017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DSM IP ASSETS B.V.